Crossmark

Periprostatic fat magnetic resonance imaging based radiomics nomogram for predicting biochemical recurrence-free survival in patients with non-metastatic prostate cancer after radical prostatectomy

Crossref DOI link: https://doi.org/10.1186/s12885-024-13207-4

Published Online: 2024-11-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Xiao-Hui

Ke, Zhi-Bin

Chen, Ze-Jia

Liu, Wen-Qi

Xue, Yu-Ting

Chen, Shao-Hao

Chen, Dong-Ning

Zheng, Qing-Shui

Xue, Xue-Yi

Wei, Yong

Xu, Ning
License Information

Text and Data Mining valid from 2024-11-27

Version of Record valid from 2024-11-27
More Information

Article History

Received: 2 February 2024

Accepted: 15 November 2024

First Online: 27 November 2024

Declarations

:

: This study was approved by the Ethics Committee of the First Affiliated Hospital of Fujian Medical University (Approved No. of ethic committee: MRCTA, ECFAH of FMU [2024]638), and all patients provided written informed consent.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below